OncoMechanics
Revolutionizing Cancer Treatment
Enhancing Immunotherapy with Mechanosensitization
OncoMechanics is at the forefront of transforming cancer therapy by leveraging biophysics to boost the effectiveness of immunotherapies.
Pioneering Oncology Innovations
OncoMechanics is dedicated to advancing cancer treatment through a groundbreaking mechanosensitization approach. Our mission is to improve patient outcomes by making tumors more susceptible to existing immunotherapies. We focus on triple-negative breast cancer (TNBC) and aim to expedite the development process by repurposing clinically approved small-molecule drugs, reducing both time and risk.
Key Features of Our Approach
Mechanosensitization Strategy
Our unique strategy enhances immunotherapy by increasing the tension and stiffness of tumor-cell membranes, facilitating stronger immune synapse formation.
Small Molecule Modulation
We utilize small molecules to modulate cell membrane mechanics, targeting pathways that influence receptor clustering and immune response.
Versatile Booster Integration
Our booster can be seamlessly integrated with existing immunotherapies, offering a cost-effective solution to enhance treatment outcomes.
Targeting Tumor-Cell Membrane Mechanics
By focusing on the mechanical properties of tumor-cell membranes, we address critical control points in receptor trafficking to overcome immune resistance.
Scientific Foundations of Mechanosensitization
Enhancing Tumor Response Through Biophysical Innovation
Innovative Small Molecule Therapy
Our cutting-edge small molecule combination therapy is designed to significantly boost the effectiveness of existing immunotherapies. By focusing on the modulation of cell membrane tension, this therapy enhances the susceptibility of tumor cells to immune attacks. Utilizing a platform technology, we employ a variety of chemical pathways, including cytoskeletal and contractility modulators, as well as membrane-lipid and cholesterol modifiers, to optimize treatment outcomes. This approach not only improves the efficacy of current treatments but also offers a cost-effective and efficient solution for advancing cancer care.
Targeting Tumor-Cell Membrane Mechanics
The Role of Membrane Properties in Immune Activation
The primary target of our therapy is the mechanical properties of tumor-cell membranes. By increasing the tension and stiffness of these membranes, we aim to enhance the organization and density of death receptors on the cell surface. This biophysical manipulation is crucial for improving immune synapse formation and facilitating effective immune-mediated apoptosis. Our focus on tumor-cell membrane mechanics addresses a critical control point in receptor trafficking, which is essential for overcoming immune resistance. By elevating receptor levels above the threshold needed for effective immune activation, we strive to reduce immune escape mechanisms commonly observed in solid tumors.
Join Our Mission to Revolutionize Cancer Treatment
Be a part of the groundbreaking journey with OncoMechanics as we redefine cancer therapy. Our innovative mechanosensitization approach is paving the way for more effective immunotherapies. Together, we can enhance patient outcomes and make significant strides in the fight against cancer.